Raybow is your Global|Green|EHS Focused|R&D Centric CDMO.

Built in 2009 and purchased from Novartis in the fall of 2019, Raybow Suzhou is an established and reputable API manufacturing facility and provides a number of lifesaving medicines to patients around the world.

The Suzhou site has room to expand further and employs leading edge waste treatment and recirculation technologies.

Contact Us

Raybow Suzhou

Hydrogenator (X3)
Pilot Production - Max Reactor
Max Commercial Reactor